A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 96
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : DF
Long Form : dermatofibroma
No. Year Title Co-occurring Abbreviation
2021 A Deep Learning Based Framework for Diagnosing Multiple Skin Diseases in a Clinical Environment. AI, AUC, AV, BCC, EAD, HEM, KAHS, LP, MN, PsO, PWS, Rosa, SD, SK, VW
2021 Skin Lesion Classification Using Additional Patient Information. AK, BCC, HAM, ISIC, MEL, NV, TTA, VASC
2020 Features of dermatofibroma in reflectance confocal microscopy. DEJ
2020 Hemosiderotic Dermatofibroma: A Rare and Atypical Variant Capable of Clinically Resembling Melanoma. HDF
2020 Role of Wnt signaling in dermatofibroma induction phenomenon. ---
2020 Skin Diseases Classification Using Deep Leaning Methods. BCC, CNN, MEL, nv
2020 Two cases of adenodermatofibroma. ---
2019 A Rare Case of Atrophic Dermatofibroma Featuring Linear Skin Dimple. ---
2019 Dermatopathological characteristics of dermatofibromas from dermatoscopic clues. ---
10  2019 Perineural Invasion as a Clue to Malignant Behavior in a Dermatofibroma. ---
11  2019 Risk-Aware Machine Learning Classifier for Skin Lesion Diagnosis. AKIEC, BCC, MEL, NV, VASC
12  2019 Unusual presentation of dermatofibroma on the face: Case report. ---
13  2018 Fluorescence microscopy for the evaluation of elastic tissue patterns within fibrous proliferations of the skin on hematoxylin-eosin-stained slides. DFSP, DMF
14  2018 [Dermatofibroma with sebaceous induction]. ---
15  2017 Induction of Desmoplastic Trichoepithelioma in a Dermatofibroma. ---
16  2017 Phosphohistone-H3 and Ki67: Useful Markers in Differentiating Dermatofibroma From Dermatofibrosarcoma Protuberans and Atypical Fibrohistiocytic Lesions. AFL, DFSP
17  2017 The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans. DFSP
18  2015 Dermatofibroma looks dermoscopically different on trunk versus extremities. ---
19  2015 Giant Hemosiderotic Dermatofibroma: The Largest Giant Dermatofibroma Reported to Date. ---
20  2015 Identification of leukocyte-specific protein 1-positive cells: a clue to the cell of origin and a marker for the diagnosis of dermatofibroma. DFSP, FXIIIa, LSP1
21  2015 Sebaceous induction in dermatofibroma: a common feature of dermatofibromas on the shoulder. ---
22  2014 Follicular induction overlying a dermatofibrosarcoma protuberans. DFSP
23  2014 miR-205 down-regulation promotes proliferation of dermatofibrosarcoma protuberans tumor cells by regulating LRP-1 and ERK phosphorylation. DFSP, ERK, LRP-1
24  2014 Multiple clustered and focally atrophic dermatofibromas (DF). ---
25  2013 CD99 expression in dermatofibrosarcoma protuberans and dermatofibroma. DFSP
26  2013 Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75. DFSP
27  2013 Mast cells in cutaneous tumors: innocent bystander or maestro conductor? AFX, AS, BCC, DFSP, HEM, KS, MC, MMIS, MP, SCC
28  2013 The involvement of fibroblast growth factor receptor signaling pathways in dermatofibroma and dermatofibrosarcoma protuberans. DFSP, FGFs, FOXN1
29  2013 [Multiple familial "eruptive" dermatofibromas]. ---
30  2012 Dermatofibromas treated with pulsed dye laser: Clinical and dermoscopic outcomes. PDL
31  2012 Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans. DFSP, IHC, MMP
32  2012 Typical and atypical dermoscopic presentations of dermatofibroma. ---
33  2011 Cellular neurothekeoma with fascicular growth features mimicking cellular dermatofibroma. CNT
34  2011 Digital dermatofibromas--common lesion, uncommon location: a series of 26 cases and review of the literature. CFH
35  2011 IGFBP7, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans. DFSP, FXIIIa, IGFBP7, ST3
36  2011 Subcutaneous dermatofibroma. ---
37  2011 The expression levels of thrombospondin-1 in dermatofibroma and dermatofibrosarcoma protuberans. DFSP, TGF-beta, TSP-1
38  2010 A case of dermatofibroma of the upper lip. ---
39  2010 Collagen triple helix repeat containing-1 in the differential diagnosis of dermatofibrosarcoma protuberans and dermatofibroma. CTHRC1, DFSP, ST3
40  2010 Estrogen receptor alpha overexpression in multinucleate cell angiohistiocytoma: new insights into the pathogenesis of a reactive process. ER, MCAH, PR, VEGF
41  2010 Immunohistochemical analysis of CXCR4 expression in fibrohistiocytic tumors. DFSP, MFH
42  2009 Dermatofibroma with intracytoplasmic eosinophilic globules: an unusual phenomenon. ---
43  2009 Dermatofibrosarcoma protuberans: a tumour of nestin-positive cutaneous mesenchymal stem cells? DFSP
44  2009 Giant dermatofibroma with granular cell changes: side-effect of bee-venom acupuncture? ---
45  2009 Morphometric analyses of elastic tissue fibers in dermatofibroma: clues to etiopathogenesis? ---
46  2009 Ulcerated dermatofibroma with osteoclast-like giant cells. ---
47  2008 Cyclooxygenase-2 expression in dermatofibroma and dermatofibrosarcoma protuberans. COX-2, DFSP
48  2008 Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. AFX, EDF, PC1
49  2008 Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma. DFSP
50  2008 [Differences of the molecular phenotypes and the histogenesis between dermatofibroma and dermatofibrosarcoma protuberans]. DC, DFSP, DRC
51  2007 Cutaneous balloon cell dermatofibroma (fibrous histiocytoma). LCA
52  2007 Proliferation of HSP47-positive skin fibroblasts in dermatofibroma. FXIIIa
53  2007 Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34. DFSP, IHC, MMP, ST3
54  2006 Dermatofibroma and dermatofibrosarcoma protuberans: a comparative ultrastructural study. DFSP, MVB
55  2006 Hemosiderotic dermatofibroma: report of one case. ---
56  2006 Multiple eruptive dermatofibromas in a patient with dermatomyositis taking prednisolone and methotrexate. ---
57  2006 The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans. DFSP, TGF
58  2006 Treatment of dermatofibroma with a 600 nm pulsed dye laser. PDL
59  2005 Characterization of factor XIIIa+ dendritic cells in dermatofibroma: Immunohistochemical, electron and immunoelectron microscopical observations. DDC, FXIIIa, RER
60  2005 Dermoscopic patterns of dermatofibroma. ---
61  2005 Microvessel density and HIF-1alpha expression correlate with malignant potential in fibrohistiocytic tumors. DFSP, HIF-1alpha, MFH, MVD
62  2005 Sclerotic fibroma-like dermatofibroma: an uncommon distinctive variant of dermatofibroma. SF-DF, SFs
63  2004 Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity. DFSP
64  2003 CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. DFSP, HA, HABP
65  2003 Decreased CD44 expression and stromal hyaluronate accumulation in myxoid dermatofibroma. HA, LSA
66  2003 Flow-cytometric DNA analysis in cutaneous fibrohistiocytic tumors. DFSP, MFH
67  2002 Clonal analysis of cutaneous fibrous histiocytoma (dermatofibroma). DFSP
68  2002 Immunohistochemical study of membrane type-matrix metalloproteinases (MT-MMPs) and matrix metalloproteinase-2 (MMP-2) in dermatofibroma and malignant fibrous histiocytoma. MFH, MMP-2, MMPs, MT-MMPs, MT-MMPs, MT1-3-MMPs
69  2002 Overrepresentation of 17q22-qter and 22q13 in dermatofibrosarcoma protuberans but not in dermatofibroma: a comparative genomic hybridization study. CGH, DFSP
70  2001 "Juvenile" xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis. JXG
71  2001 Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa. DFSP
72  2000 Dermatofibroma is a clonal proliferative disease. ---
73  2000 Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans? DFSP
74  1999 Dermatofibroma with granular cells: a report of two cases. ---
75  1999 Dermatofibrosarcoma protuberans: an analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression. DFSP, DFSP-FS, FS, LI, MFH
76  1999 nm23 protein expression and p53 immunoreactivity in cutaneous fibrohistiocytic tumors. AFX, DFSP
77  1999 [Fibrohistiocytic skin lesions]. ---
78  1998 Expression of cathepsins in dermal fibrous tumors: an immunohistochemical study. AFX, DFS
79  1998 p53 protein immunoreactivity in fibrohistiocytic tumors of the skin. AFX, DFSP
80  1998 Phenotype and proliferation characteristics of cultured spindle-shaped cells obtained from normal human skin and lesions of dermatofibroma, Kaposi's sarcoma, and dermatofibrosarcoma protuberans: a comparison with fibroblast and endothelial cells of the dermis. DFSP, KS, KSGM
81  1998 Possible involvement of interleukin-1 in the pathogenesis of dermatofibroma. IL-1, RT-PCR
82  1997 Epithelial induction in dermatofibroma: a role for the epidermal growth factor (EGF) receptor. BCC, EGF, EGFR
83  1997 Immunohistochemical analysis of platelet-derived growth factor and its receptors in fibrohistiocytic tumors. DFSP, MFH, PDGF
84  1996 Dermatofibroma and dermatofibrosarcoma protuberans: an immunohistochemical study reveals distinctive antigenic profiles. DFSP, FVIII-RA, FXIIIa
85  1996 Expression of the tissue metalloproteinase inhibitors TIMP-1 and TIMP-2 in malignant fibrous histiocytomas and dermatofibromas as studied by in situ hybridization and immunohistochemistry. ISH, MFH
86  1995 Comparison of p53 expression in dermatofibrosarcoma protuberans and dermatofibroma: lack of correlation with proliferation rate. DFSP
87  1995 Dermatofibroma with myxoid changes in a patient with psoriasis. ---
88  1995 Immunohistochemistry of dermatofibromas and benign fibrous histiocytomas. BFH
89  1994 Cell-type related and spatial variation in the expression of integrins in cutaneous tumors. BCC
90  1994 Dermatofibroma: superficial fibrous proliferation with reactive histiocytes. A multiple immunostaining analysis. PCNA
91  1993 CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. DFSP
92  1993 Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors. AFX, DFSP, FXIIIa
93  1992 Dermatofibroma with osteoclast-like giant cells. ---
94  1990 Benign fibrous histiocytoma of the skin with potential for local recurrence: a tumor to be distinguished from dermatofibroma. BFH, CBFH
95  1984 Enzyme histochemical observation of fibrohistiocytic tumors. ACP, AFX, beta-Gl, DFSP, GCT, MFH, NGA, NS-E
96  1984 Tissue cultures of benign and malignant fibrous histiocytomas: SEM observations. AFX, DFSP, MFH